JPMorgan Chase & Co. Forecasts Strong Price Appreciation for NeuroPace (NASDAQ:NPCE) Stock
NeuroPace (NASDAQ:NPCE – Get Free Report) had its price objective boosted by equities researchers at JPMorgan Chase & Co. from $14.00 to $16.00 in a research note issued to investors on Wednesday,Benzinga reports. The firm currently has an “overweight” rating on the stock. JPMorgan Chase & Co.‘s price objective indicates a potential downside of 6.32% […]
NeuroPace (NASDAQ:NPCE – Get Free Report) had its price objective boosted by equities researchers at JPMorgan Chase & Co. from $14.00 to $16.00 in a research note issued to investors on Wednesday,Benzinga reports. The firm currently has an “overweight” rating on the stock. JPMorgan Chase & Co.‘s price objective indicates a potential downside of 6.32% […]
